Ozue Ezeife

Ozue created AlphaCitation after more than a decade working at the intersection of market access, pricing, evidence and commercial strategy in healthcare.

He spent 11 years at Novo Nordisk, most recently as Regional Pricing & Access Director, with responsibilities spanning Asia-Pacific and earlier roles across Africa and the Middle East. His work included obesity and diabetes strategy, semaglutide, rare blood and endocrine disorders, payer engagement, pricing, reimbursement, tenders and market development across highly varied healthcare systems.

That experience shaped the thinking behind AlphaCitation: as AI increasingly influences how products and categories are understood, brand teams need arigorous way to see what AI is saying, trace why it is saying it, verify the evidence behind it, and act on the commercial implications.